Marek Dziki

SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore.

Part of BIOTON SA, Pharmatex Italia SRL engages in pharmaceuticals production. The company is based in Milan, Italy. The Italian company was founded in 1977. Nicola Cadei has been the CEO of the company since 2016. Pharmatex Italia was acquired by BIOTON SA on June 08, 2006 for $6.39 million.

Part of Merck KGaA, Merck Specialities Pvt Ltd. is a pharmaceutical manufacturing and Indian distribution company. The company is based in Mumbai, India and was founded in 2005.

Merck KGaA & Co. Werk Spittal manufactures and supplies pharmaceutical products. The company is headquartered in Spittal an der Drau, Austria.

Technopark Skolkovo LLC is a Russian company that drives innovation and development in Russia's science and technology sectors. The non-profit company is based in Moscow, Russian Federation and was founded in 2010.